Theravance Biopharma To Cut 75% Jobs, Board Size; To Focus On Respiratory Disease Portfolio

Theravance Biopharma, Inc. (TBPH), a company primarily focused on the discovery, development, and commercialization of organ-selective medicines, Wednesday announced strategic actions to focus on respiratory disease portfolio, with significant cost reduction program, including around 75 percent of job cuts.

The decision comes along with the announcement that its Phase 3 study of ampreloxetine for the treatment of symptomatic neurogenic orthostatic hypotension or nOH did not meet the primary endpoint.

In pre-market activity on Nasdaq, Theravance Biopharma shares were losing around 38 percent to trade at $5.

In a statement, the company said it plans to focus on developing and commercializing respiratory therapeutics, and will immediately initiate a significant cost reduction program.

The company's headcount will be reduced by approximately 75%, an estimated 270 positions. Around 75% of the planned reduction is expected to be completed in November 2021 and the remainder to be completed in February 2022.

Total annualized operating expense savings are expected to be approximately $165 million in 2022.

By implementing these strategic actions, Theravance expects to become sustainably cash flow positive beginning in the second half of 2022.

In addition, the company intends to significantly narrow its R&D focus on its core respiratory assets.

In order to implement this plan, the company will halt the development of all non-respiratory disease related programs except that it will close-out the izencitinib Phase 2 Crohn's disease Study 0157 (NCT03758443) and the ampreloxetine Phase 3 REDWOOD Study 0170 (NCT03829657).

The company has also decided to reduce the size of its Board, and is announcing the resignations from the Board of two long-term directors: George Whitesides, and Robert Gunderson, Jr., effective September 14, and September 11, respectively.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has rolled out the tipping feature called "Tips" for everyone around the globe using the microblogging site with more payment options to choose from, including cryptocurrencies such as Bitcoin. This is a new way for people to receive and show support on Twitter with money. The feature is currently available on iOS and will be available on Android over the coming weeks. Amazon.com has launched weekly Max-Your-Vax Sweepstakes to encourage their employees to get vaccinated against COVID-19. The sweepstakes began on August 6, 2021 and ends on October 21, 2021, with six draws during the sweepstakes period for 18 prizes worth nearly $2 million, including cash prizes, new vehicle or cash and vacation plus 40 hours of Paid Time Off. Target Corp. announced its plans to hire 100,000 seasonal team members at its stores across the country for this holiday shopping season, though fewer than previous years. With this, the company aims to invest in more flexible scheduling, training, pay and benefits for its existing team members. In a statement, the company said it is also offering around 5 million more hours to its existing staff.
Follow RTT